** = Publikationen gelistet in SCI/SSCI/Pubmed
** Haudum, CW; Kolesnik, E; Colantonio, C; Mursic, I; Url-Michitsch, M; Tomaschitz, A; Glantschnig, T; Hutz, B; Lind, A; Schweighofer, N; Reiter, C; Ablasser, K; Wallner, M; Tripolt, NJ; Pieske-Kraigher, E; Madl, T; Springer, A; Seidel, G; Wedrich, A; Zirlik, A; Krahn, T; Stauber, R; Pieske, B; Pieber, TR; Verheyen, N; Obermayer-Pietsch, B; Schmidt, A
Cohort profile: 'Biomarkers of Personalised Medicine' (BioPersMed): a single-centre prospective observational cohort study in Graz/Austria to evaluate novel biomarkers in cardiovascular and metabolic diseases.
BMJ Open. 2022; 12(4):e058890
Doi: 10.1136/bmjopen-2021-058890
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** von, Lewinski, D; Kolesnik, E; Tripolt, NJ; Pferschy, PN; Benedikt, M; Wallner, M; Alber, H; Berger, R; Lichtenauer, M; Saely, CH; Moertl, D; Auersperg, P; Reiter, C; Rieder, T; Siller-Matula, JM; Gager, GM; Hasun, M; Weidinger, F; Pieber, TR; Zechner, PM; Herrmann, M; Zirlik, A; Holman, RR; Oulhaj, A; Sourij, H
Empagliflozin in acute myocardial infarction: the EMMY trial.
Eur Heart J. 2022; 43(41):4421-4432
Doi: 10.1093/eurheartj/ehac494
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG